共 50 条
- [5] Chimeric antigen receptor (CAR) T-cell therapy for people with relapsed or refractory diffuse large B-cell lymphoma [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (09):
- [7] Cost-Effectiveness of Chimeric Antigen Receptor T Cell Therapy in Patients with Relapsed or Refractory Large B Cell Lymphoma: No Impact of Site of Care [J]. Advances in Therapy, 2022, 39 : 3560 - 3577